Abstract
This case series reports on the safety and efficacy of the levonorgestrel 52-mg intrauterine
system in adolescent and young adult solid organ transplant recipients. All patients
used the device for contraception, with no documented cases of disseminated pelvic
infection or unplanned pregnancy.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Pregnancy in recipients of solid organs – effects on mother and child.N Engl J Med. 2006; 354: 1281-1293
- Contraceptive options for women with a history of solid-organ transplantation.Transplantation. 2013; 95: 1183-1186
- Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.Clin Transpl. 2010; : 68-85
- Impact of successful liver transplantation on reproductive function and sexuality in women with advanced liver disease.Transplant Proc. 2004; 36: 943-944
- Menstrual characteristics and pregnancy in women after renal transplantation.Int J Gynaecol Obstet. 2004; 85: 119-125
- Menstrual problems among kidney transplant recipients.Transplant Proc. 2003; 35: 2720-2721
- Postrenal transplant improvement of sexual function.Transplant Proc. 1999; 31: 3144
- Obstet Gynecol. 2012; 120: 983-988
- Policy statement: contraception for adolescents.Pediatrics. 2014; 134: e1244-e1256
- J Obstet Gynaecol Can. 2014; 36: 266-276
- U.S. medical eligibility criteria for contraceptive use, 2016.MMWR Recomm Rep. 2016; 65: 1-103
- Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation.Am J Transplant. 2005; 5: 1592-1599
- Intrauterine contraceptive device failures in renal transplant patients.J Reprod Med. 1981; 26: 99-102
- Obstet Gynecol. 2011; 118: 184-196
- Is the intrauterine device appropriate contraception for HIV-1-infected women?.Br J Obstet Gynaecol. 2001; 108: 784-790
- Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review.Contraception. 2012; 86: 288-289
- Changes in genital tract immune cell populations after initiation of intrauterine contraception.Am J Obstet Gynecol. 2014; 211: 489.e1-489.e9
- A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.Am J Obstet Gynecol. 2016; 215: 599.e1-599.e6
- Contraceptive use among solid organ transplant patients: a systematic review.Contraception. 2010; 82: 102-112
Article info
Publication history
Published online: December 07, 2016
Accepted:
November 30,
2016
Received in revised form:
November 29,
2016
Received:
September 15,
2016
Footnotes
☆Conflicts of interest: none.
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
